MyoPowers is proud to announce that, for the first time ever, on Saturday May 7th, a poster and abstract will be presented at AUA 2016 in San Diego with prestigious KOLs among the authors. The poster is called "A Novel Telemetry Activated Sphincter for the Treatment of Severe Stress Urinary Incontinence in Male and Female Patients" and will be presented by Pr Roger Dmochowski.
News and Events
On April 4th, 2016, BioTech Finance, the leading French speaking Biotech / Medtech magazine published a very nice article about MyoPowers fundraising effort.
A big thank you to BioTech Finance for covering us. By courtesy of BioTech Finance.
June 22, 2015 – Saint-Louis, France – MyoPowers, a French medtech company developing an artificial urinary sphincter to help patients suffering from stress urinary incontinence, today announces it was granted €1 million by the French public investment bank Bpifrance and the Alsace Region, as part of French public efforts to support promising innovative companies.
Les Echos, the French leading Economic Newspaper reports on MyoPowers' Capital Increase:
Taking the opportunity of MyoPowers capital increase, Eric Rambeaux, MyoPowers'CEO gave an interview to BioTech Finance, the leading life science blog in France (In French).
Can be listened to on: http://blog.biotech-finances.com/sphincter-urinaire-myopowers-veut-garder-le-controle/#sthash.uqxAiXxo.dpu
June 3rd, 2015 – Saint-Louis, France – MyoPowers, a French medtech company developing an artificial urinary sphincter to help patients suffering from stress urinary incontinence, announces today the closing of a € 4.5 million financing round with longstanding investors Truffle Capital, Novartis Venture Fund and Gran Plasa.
MyoPowers to present at 19th MedTech Investing Europe conference (MTI) in Paris.
January 1st, 2014 - MyoPowers has been re-certified to EN ISO 13485:2012 for the design, development, manufacturing and distribution of active implantable medical devices for the treatment of incontinence. TUEV SUED served as certification body.